Janux Therapeutics EPS Basic from Accounting Change (Quarterly) Analysis

Janux Therapeutics, Inc. (JANX)

13.40 +0.25 (+1.90%) USD | NASDAQ | Jan 21, 10:11

View EPS Basic from Accounting Change (Quarterly) for JANX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Accounting Change (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	--
Ionis Pharmaceuticals, Inc.	--
MannKind Corp.	--
Madrigal Pharmaceuticals, Inc.	--
Editas Medicine, Inc.	--